对于先前治疗的骨髓纤维化有哪些治疗选择?
Cassandre Petit1, Hugues de Lavallade1, Claire Harrison1
1Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Expert review of hematology
|November 4, 2024
概括
骨髓纤维化 (MF) 治疗涉及JAK抑制剂 (JAKi),但如果初始治疗失败,则存在其他选择. 较新的JAKi和干细胞移植为MF患者提供了替代方案.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓纤维化 (MF) 的特征是JAK/STAT通路的破坏.
- 简氏激酶抑制剂 (JAKi) 现在是MF的第一线治疗方法.
- 对于那些对初始JAKi疗法没有反应的患者,需要进行替代治疗.
研究的目的:
- 审查MF患者的管理策略.
- 在一线JAKi失败后,专注于治疗选择.
- 提供当前MF治疗景观的概述.
主要方法:
- 在PubMed,Cochrane和clinicaltrials.gov.gov的文献搜索中进行.
- 对骨髓纤维化治疗策略的审查.
- 对JAK抑制剂和替代治疗方法的分析.
主要成果:
- 卢克索利提尼布的疗效可能会在3-4年后降低,并可能产生副作用.
- 三种较新的JAK抑制剂提供了具有可比功效和各种副作用配置文件的替代品.
- 同源干细胞移植是选择多发性肌痛患者的治疗选择.
结论:
- 目前正在进行的研究重点是改进一线JAKi治疗方法和管理多发性肺炎中JAKi耐药性.
- 未来的MF疗法可能包括新的药物组合或针对特定突变的免疫疗法.
- 共同努力对于推进多发性肺炎治疗和患者护理至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Bone Marrow Sampling and Transplants
292
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
292
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Introduction to Fibroblasts
3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
142
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142


